Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 29, 2020 at 11:12 AM EDT

Moderna’s Financials Aren’t Even the Best Part of Its Report

When Moderna reported its most recent quarterly results before the markets opened on Thursday, the earnings (or loss in this…

Douglas A. McIntyre | Oct 29, 2020 at 7:19 AM EDT

COVID-19 Has Shut Down These American Cities at Night

The three largest American cities most recently under curfew orders from their governments are El Paso, Newark and Chicago.

Jon C. Ogg | Oct 28, 2020 at 7:01 PM EDT

Did Regeneron Just Revive Hopes About Beating COVID-19?

The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in…

Chris Lange | Oct 28, 2020 at 4:25 PM EDT

These Two Major Biotechs Are Bouncing Back With Q3 Results

Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.

Paul Ausick | Oct 28, 2020 at 11:19 AM EDT

More Than Half of US Adults Worry About Medical Bankruptcy, Debt

More than half of American adults are concerned that an unexpected medical bill could lead to crushing debt or bankruptcy.

Chris Lange | Oct 27, 2020 at 11:00 AM EDT

Does Catabasis Pharma Have a Chance After This DMD Study Flop?

Catabasis Pharmaceuticalswas absolutely devastated on Tuesday after the company announced top-line results from its late-stage study in muscular dystrophy.

Chris Lange | Oct 27, 2020 at 10:49 AM EDT

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday, and investors were not thrilled about…

Chris Lange | Oct 27, 2020 at 9:55 AM EDT

Major Biotechs Have Short Sellers Looking Both Ways

The October 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Oct 26, 2020 at 11:34 AM EDT

The Big COVID-19 Update at BioSig Technologies

BioSig Technologies was absolutely crushed on Monday after the company announced that it would be halting its midstage coronavirus study.

Chris Lange | Oct 26, 2020 at 10:56 AM EDT

Atea Pharma Announces Potential Pricing for IPO

Clinical-stage biopharmaceutical company Atea Pharma intends to price 11 million shares for and intial public offering valued up to more…

Paul Ausick | Oct 26, 2020 at 9:46 AM EDT

Why HCA Healthcare Earnings Aren’t Moving Investors

HCA Healthcare reported earnings per share that were well short of estimates but beat on revenues.

Douglas A. McIntyre | Oct 26, 2020 at 8:37 AM EDT

In Badly Battered New York, COVID-19 Cases Pass 500,000

New York's confirmed COVID-19 cases have topped 500,000. After slowing for three months, have started to move higher at a…

Douglas A. McIntyre | Oct 26, 2020 at 7:16 AM EDT

COVID-19: Texas Passes California to Become Hardest-Hit State

For over two months, California had the most COVID-19 confirmed cases. That changed today as the Texas confirmed case count…

Douglas A. McIntyre | Oct 25, 2020 at 7:10 AM EDT

Texas Become Second State With Over 900,000 Cases

Texas became only the second state to have over 900,000 confirmed COVID-19 cases as its total reached 906,033. That places…

Douglas A. McIntyre | Oct 24, 2020 at 2:54 PM EDT

Bing COVID-19 Tracker: Daily U.S. Cases Top 100,000 For First Time

According to the Bing COVID-19 Tracker, new cases in the U.S. rose by 105,411 during the last day, the first…

1 … 35 36 37 38 39 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Moderna’s Financials Aren’t Even the Best Part of Its Report

COVID-19 Has Shut Down These American Cities at Night

Did Regeneron Just Revive Hopes About Beating COVID-19?

These Two Major Biotechs Are Bouncing Back With Q3 Results

More Than Half of US Adults Worry About Medical Bankruptcy, Debt

Does Catabasis Pharma Have a Chance After This DMD Study Flop?

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Major Biotechs Have Short Sellers Looking Both Ways

The Big COVID-19 Update at BioSig Technologies

Atea Pharma Announces Potential Pricing for IPO

Why HCA Healthcare Earnings Aren’t Moving Investors

In Badly Battered New York, COVID-19 Cases Pass 500,000

COVID-19: Texas Passes California to Become Hardest-Hit State

Texas Become Second State With Over 900,000 Cases

Bing COVID-19 Tracker: Daily U.S. Cases Top 100,000 For First Time

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

The 5% CDs Everyone Bought in 2024 Are Quietly Raising 2026 Medicare Premiums

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

The 5% CDs Everyone Bought in 2024 Are Quietly Raising 2026 Medicare Premiums

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Health and Healthcare Articles

All Health and Healthcare Articles

Moderna’s Financials Aren’t Even the Best Part of Its Report

COVID-19 Has Shut Down These American Cities at Night

Did Regeneron Just Revive Hopes About Beating COVID-19?

These Two Major Biotechs Are Bouncing Back With Q3 Results

More Than Half of US Adults Worry About Medical Bankruptcy, Debt

Does Catabasis Pharma Have a Chance After This DMD Study Flop?

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Major Biotechs Have Short Sellers Looking Both Ways

The Big COVID-19 Update at BioSig Technologies

Atea Pharma Announces Potential Pricing for IPO

Why HCA Healthcare Earnings Aren’t Moving Investors

In Badly Battered New York, COVID-19 Cases Pass 500,000

COVID-19: Texas Passes California to Become Hardest-Hit State

Texas Become Second State With Over 900,000 Cases

Bing COVID-19 Tracker: Daily U.S. Cases Top 100,000 For First Time

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

The 5% CDs Everyone Bought in 2024 Are Quietly Raising 2026 Medicare Premiums

Featured Reads

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

The 5% CDs Everyone Bought in 2024 Are Quietly Raising 2026 Medicare Premiums